Zesnil 12.5 Tablet
Prescription Required
Product introduction
Zesnil 12.5 Tablet is a prescription medicine used in the treatment of fibromyalgia (a condition in which there are generalized pain and tenderness in the body) and depression. It works by increasing the level of chemical messengers (serotonin and noradrenaline), helping in faster recovery.
Zesnil 12.5 Tablet is used to treat depression and anxiety disorder.
Zesnil 12.5 Tablet is used to treat depression and anxiety disorder.
Uses of Zesnil Tablet
Benefits of Zesnil Tablet
In Fibromyalgia
Zesnil 12.5 Tablet may also be used to treat pain in people with fibromyalgia. It reduces pain and also the mood changes, sleep problems, and tiredness that can be caused by the pain. It interferes with pain messages traveling through the brain. Taking this medicine regularly will have an impact on your overall quality of life. Keep taking the medicine until your doctor advises you to stop.
In Depression
Zesnil 12.5 Tablet helps in maintaining the balance of certain chemicals in the brain that affect mood and behavior. This improves your mood, relieves anxiety, tension, helps you sleep better, and increases your energy levels. Zesnil 12.5 Tablet prevents extreme mood changes and helps you feel less agitated. You may experience fewer episodes of depression and low mood.
Side effects of Zesnil Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Zesnil
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Constipation
- Anxiety
- Decreased appetite
- Increased sweating
- Sexual dysfunction
How to use Zesnil Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zesnil 12.5 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Zesnil 12.5 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Zesnil 12.5 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Zesnil 12.5 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Zesnil 12.5 Tablet may cause side effects which could affect your ability to drive.
As Zesnil 12.5 Tablet may impair your thinking or reactions and this may affect your ability to drive.
As Zesnil 12.5 Tablet may impair your thinking or reactions and this may affect your ability to drive.
Kidney
CAUTION
Zesnil 12.5 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Zesnil 12.5 Tablet may be needed. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Zesnil 12.5 Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Zesnil 12.5 Tablet may not be needed in these patients. Please consult your doctor.
Caution is advised in patients with the severe liver disease.
Caution is advised in patients with the severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- It may take 2 to 4 weeks for Zesnil 12.5 Tablet to start working. Keep taking it as prescribed.
- It may cause dizziness and sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- Avoid consuming alcohol when taking Zesnil 12.5 Tablet as it may cause excessive drowsiness and increase the risk of liver damage.
- It may cause a sensation of restlessness, especially when you first start taking it. Inform your doctor if this happens to you.
- Talk to your doctor if you notice sudden mood changes or develop suicidal thoughts.
- Do not stop taking the medication suddenly without talking to your doctor.
Fact Box
Chemical Class
Phenylacetamide Derivative
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Patient concerns
FAQs
Q. Is Zesnil 12.5 Tablet addictive?
Zesnil 12.5 Tablet does not cause addiction
Q. Is Zesnil 12.5 Tablet narcotic?
Zesnil 12.5 Tablet is not a narcotic
Q. Is Zesnil 12.5 Tablet a generic or a controlled substance?
Zesnil 12.5 Tablet is a generic and not a controlled substance
Q. Does Zesnil 12.5 Tablet cause weight loss?
Zesnil 12.5 Tablet may cause this side effect. Call your doctor if you experience any unusual problems during your treatment.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Milnacipran. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 435-39.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 921.
- Milnacipran. New York, New York: Forest Laboratories, Inc.; 2009 [revised Jan. 2009]. [Accessed 25 Mar 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Milnacipran. [Updated 2018 Oct 31]. Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 25 Mar. 2019] (online) Available from:
Marketer details
Name: Consern Pharma Limited
Address: Consern Pharma Private Limited, Kuljive Mahajan(Mg. Director), Rural Focal Point, V.P.O. Tibba, Ludhiana - 141120, Punjab, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
35 people viewed this recentlyMRP
₹40
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me